Monitoring carbon dioxide in mechanically ventilated patients during hyperbaric treatment

What Researchers Did

Researchers studied 10 intubated and ventilatory stable patients during hyperbaric oxygen therapy (HBOT) to assess the correlation between end-tidal, transcutaneous, and arterial carbon dioxide measurements.

What They Found

A good correlation was observed between end-tidal carbon dioxide (P(ET)CO2) and arterial carbon dioxide (P(a)CO2) (r² = 0.83), with P(ET)CO2 averaging 2.22 kPa higher than P(a)CO2 (LoA ± 2.4 kPa). In contrast, transcutaneous carbon dioxide (P(TC)CO2) showed a poor correlation (r² = 0.24) and was, on average, 2.16 kPa lower than P(a)CO2 (LoA ± 3.2 kPa).

What This Means for Canadian Patients

For Canadian patients undergoing mechanical ventilation during hyperbaric oxygen therapy, end-tidal carbon dioxide monitoring may provide a more precise, non-invasive estimate of arterial carbon dioxide levels than transcutaneous methods. This could potentially reduce the need for frequent arterial blood gas sampling, improving patient comfort and safety during specialized treatments.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The study was limited by a small sample size of 10 patients and the abstract suggests significant variability in the findings.